Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation

Citation
Fca. Gomes et al., Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation, BRAZ J MED, 32(5), 1999, pp. 619-631
Citations number
67
Categorie Soggetti
Medical Research General Topics
Journal title
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
ISSN journal
0100879X → ACNP
Volume
32
Issue
5
Year of publication
1999
Pages
619 - 631
Database
ISI
SICI code
0100-879X(199905)32:5<619:GFAP(M>2.0.ZU;2-H
Abstract
Intermediate filament (IF) proteins constitute an extremely large multigene family of developmentally and tissue-regulated cytoskeleton proteins abund ant in most vertebrate cell types. Astrocyte precursors of the CNS usually express vimentin as the major IF. Astrocyte maturation is followed by a swi tch between vimentin and glial fibrillary acidic protein (GFAP) expression, with the latter being recognized as an astrocyte maturation marker. Levels of GFAP are regulated under developmental and pathological conditions. Upr egulation of GFAP expression is one of the main characteristics of the astr ocytic reaction commonly observed after CNS lesion. In this way, studies on GFAP regulation have been shown to be useful to understand not only brain physiology but also neurological disease. Modulators of GFAP expression inc lude several hormones such as thyroid hormone, glucocorticoids and several growth factors such as FGF, CNTF and TGF beta, among others. Studies of the GFAP gene have already identified several putative growth factor binding d omains in its promoter region. Data obtained from transgenic and knockout m ice have provided new insights into IF protein functions. This review highl ights the most recent studies on the regulation of IF function by growth fa ctors and hormones.